CT45A1 and colorectal carcinoma: MSI‐H CRC patients whose survival data are available were further analyzed, and we found that patients with CT45A1‐positive tumors also exhibited worse survival outcomes compared to patients with CT45A1‐negative tumors (Fig. 6G).